Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verinurad Monotherapy in Gout
NCT01927198Phase 2Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Aug 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of verinurad in gout, sponsored by Ardea Biosciences, Inc.. Started Aug 2013; status: completed.
02
Drugs
verinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT01927198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01927198.